K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · CAH
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | CAH | CARDINAL HEALTH INC | CARDINAL HEALTH, INC. | $1.3M | Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade p |
| 2026-04-20 | CAH | CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | $120K | Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy |
| 2026-04-20 | CAH | CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | TARPLIN, DOWNS & YOUNG, LLC | $80K | General issues related to drug shortages, supply chain Federal budget issues |
| 2026-04-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $30K | Health care and FDA/agriculture appropriations. Enteral nutrition. |
| 2026-04-17 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs |
| 2026-04-17 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and m |
| 2026-01-20 | CAH | CARDINAL HEALTH INC | CARDINAL HEALTH, INC. | $740K | Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act). Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, tr |
| 2026-01-20 | CAH | CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | $120K | Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy |
| 2026-01-20 | CAH | CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | TARPLIN, DOWNS & YOUNG, LLC | $80K | General issues related to drug shortages, supply chain Federal budget issues |
| 2026-01-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $30K | Health care and FDA/agriculture appropriations. Enteral nutrition. |
| 2026-01-19 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and m |
| 2026-01-15 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $60K | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. The Preserving Patient Access to Long-Term Care Pharmacies Act (H.R. 5031 / S. 3159) |
| 2025-10-23 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $0 | |
| 2025-10-22 | CAH | CARDINAL HEALTH INC | CARDINAL HEALTH, INC. | $450K | Issues related to tariffs, trade, and U.S. trade policy. Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tax reform and 2017 Tax Cuts and Jobs Act. Issues related to tariffs, trade, and U.S. trade policy. |
| 2025-10-20 | CAH | CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | $120K | Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy |
| 2025-10-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $0 | health care and FDA/agriculture appropriations |
| 2025-10-20 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $0 | |
| 2025-10-20 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $0 | |
| 2025-10-19 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and medical products and |
| 2025-10-17 | CAH | CARDINAL HEALTH INC | CARDINAL HEALTH, INC. | $390K | Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025). Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, trade, and U.S. trade policy. |
| 2025-10-17 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $10K | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. |
| 2025-10-15 | CAH | CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | TARPLIN, DOWNS & YOUNG, LLC | $80K | General issues related to drug shortages, supply chain Federal budget issues |
| 2025-09-09 | CAH | CARDINAL HEALTH INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $0 | General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. |
| 2025-08-26 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $30K | health care and FDA/agriculture appropriations |
| 2025-08-22 | CAH | CARDINAL HEALTH INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $0 | Health care and FDA/agriculture appropriations. |
| 2025-07-21 | CAH | CARDINAL HEALTH INC | CARDINAL HEALTH, INC. | $420K | Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tax reform and 2017 Tax Cuts and Jobs Act. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, trade, and U.S. trade policy. |
| 2025-07-21 | CAH | CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | $130K | Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy |
| 2025-07-21 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $20K | General health care issues |
| 2025-07-18 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Tariff-related matters regarding the distribution and sale of pharmaceutical and medical products and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and FY 2026 Labor-HHS Appropriations. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and |
| 2025-07-16 | CAH | CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | TARPLIN, DOWNS & YOUNG, LLC | $80K | General issues related to drug shortages, supply chain Federal budget issues |
| 2025-04-21 | CAH | CARDINAL HEALTH INC | CARDINAL HEALTH, INC. | $1.1M | Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health, food is medicine, acute hospital care at home waiver; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, pandemic preparedness, and product shortages. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation bottlenecks. Issues related to tax reform and 2017 Tax Cuts and Jobs Act. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, trade, and U.S. trade policy. |
| 2025-04-21 | CAH | CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | $80K | Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy |
| 2025-04-21 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. |
| 2025-04-21 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $10K | Issues related to pharmaceutical drugs and medical devices Issues related to medical device and pharmaceutical tariffs |
| 2025-04-16 | CAH | CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | TARPLIN, DOWNS & YOUNG, LLC | $80K | General issues related to drug shortages, supply chain Federal budget issues |
| 2025-01-21 | CAH | CARDINAL HEALTH | BGR GOVERNMENT AFFAIRS | $30K | Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy |
| 2025-01-21 | CAH | CARDINAL HEALTH INC. | TWENTY-FIRST CENTURY GROUP, INC. | $24K | Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; Drug Supply Chain Security Act (DSCSA), and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; Drug Supply Chain Security Act (DSCSA), and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Drug Supply Chain Security Act (DSCSA), and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; drug shortages; Food as Medicine; and the healthcare supply chain; H.R. 9029, FY 2025 LHHS Appropriations. |
| 2025-01-21 | CAH | CARDINAL HEALTH INC. | CROWELL & MORING LLP | $0 | Issues related to pharmaceutical drugs and medical devices |